Provided by Tiger Fintech (Singapore) Pte. Ltd.

Replimune Group Inc.

9.29
-0.0400-0.43%
Post-market: 9.590.3000+3.23%16:22 EDT
Volume:1.25M
Turnover:11.68M
Market Cap:716.14M
PE:-3.03
High:9.64
Open:9.45
Low:9.15
Close:9.33
Loading ...

Wedbush Keeps Their Buy Rating on Replimune Group (REPL)

TIPRANKS
·
25 Jun

Cantor Fitzgerald Keeps Their Buy Rating on Replimune Group (REPL)

TIPRANKS
·
25 Jun

Replimune Group Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
20 Jun

Cantor Fitzgerald Initiates Replimune Group at Overweight

MT Newswires Live
·
20 Jun

Replimune Group (REPL) Gets a Buy from Jefferies

TIPRANKS
·
06 Jun

J.P. Morgan Sticks to Their Buy Rating for Replimune Group (REPL)

TIPRANKS
·
04 Jun

Replimune Group Is Maintained at Overweight by Piper Sandler

Dow Jones
·
02 Jun

U.S. RESEARCH ROUNDUP- Charter Communications, Ford, General Motors

Reuters
·
02 Jun

Replimune Group Inc : Piper Sandler Raises Target Price to $22 From $14

THOMSON REUTERS
·
02 Jun

Replimune presents two posters on data updates for RP1 at 2025 ASCO

TIPRANKS
·
02 Jun

BRIEF-Replimune Presents New Analyses From The IGNYTE Study Of RP1 Plus Nivolumab In Anti-PD1 Failed Melanoma At The 2025 American Society Of Clinical Oncology (ASCO) Annual Meeting

Reuters
·
01 Jun

Replimune Presents New Analyses From the Ignyte Study of Rp1 Plus Nivolumab in Anti-Pd1 Failed Melanoma at the 2025 American Society of Clinical Oncology (Asco) Annual Meeting

THOMSON REUTERS
·
01 Jun

Replimune Group Inc - Rp1 Plus Nivolumab Shows 32.9% Orr in Anti-Pd-1 Failed Melanoma Patients

THOMSON REUTERS
·
01 Jun

Replimune Group’s Internal Control Weaknesses Threaten Financial Stability and Investor Confidence

TIPRANKS
·
24 May

Stock Track | Replimune Group Plummets 5.37% Pre-Market on $250M Mixed Shelf Filing and Insider Sales

Stock Track
·
23 May

Replimune Group (REPL) Receives a Buy from Wedbush

TIPRANKS
·
23 May

BRIEF-Replimune Group Inc Files For Offer & Resale Of 25.1 Million Shares Of Common Stock Offered By Selling Stockholders - SEC Filing

Reuters
·
23 May

BRIEF-Replimune Group Inc Files For Mixed Shelf Of Up To $250 Million – SEC Filing

Reuters
·
23 May

H.C. Wainwright Reaffirms Their Buy Rating on Replimune Group (REPL)

TIPRANKS
·
23 May

Stock Track | Replimune Group Soars 5.71% Pre-market on $250 Million Mixed Shelf Filing

Stock Track
·
23 May